GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read MoreGSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read MoreWhat the actual cluck? The latest seriously questionable social-media trend apparently has people sautéing chicken…
Read MorePeople who have had COVID-19 are facing a higher risk of neurological and psychiatric conditions…
Read MoreIt was nothing to sneeze at. A man who co-created the cold remedy, Zicam, has…
Read More